The Leading Community for Trusted Peptide Research & Insights
Research summaries, dosing protocols, and community reports for peptides. Built on clinical data and real-world experiences.
Healing peptides represent one of the most actively researched areas in peptide science. These compounds have been studied for their potential to accelerate tissue repair, reduce inflammation, and support recovery from injuries ranging from tendon tears to gut lining damage.
The peptides below belong to the "Injury, Repair & Recovery" category in our database. Each has a distinct mechanism of action — from promoting angiogenesis and cell migration to modulating inflammatory pathways. Understanding these differences is key to evaluating which peptides have the strongest evidence for specific recovery goals.
BPC-157 (Body Protection Compound-157) is the most extensively studied healing peptide, with over 100 published studies examining its effects on tissue repair, gut healing, and anti-inflammatory activity. TB-500 (Thymosin Beta-4) is another well-researched option, particularly for wound healing and muscle repair.
BPC-157 and TB-500 are commonly researched together as they have complementary mechanisms — BPC-157 promotes angiogenesis and modulates growth factors, while TB-500 promotes cell migration and reduces inflammation. However, stacking protocols should be based on published research, not anecdotal reports.
In preclinical studies, tissue repair effects from peptides like BPC-157 and TB-500 are typically observed within 1-4 weeks. However, clinical timelines vary significantly depending on the type and severity of injury, the specific peptide, and the administration route.